Tatva Chintan Pharma Chem Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	87.91	113.74	353.04	273.65	630.17
Short-Term Investments	-	3.27	3.13	138.5	8.02
Trading Asset Securities	-	-	100.51	-	-
Cash & Short-Term Investments	87.91	117.01	456.68	412.15	638.19
Cash Growth	-24.87%	-74.38%	10.80%	-35.42%	1098.70%
Accounts Receivable	1,190	895.49	720.24	875.03	584.27
Other Receivables	-	11.9	5.18	3.21	27.21
Receivables	1,193	909.76	727.83	879.96	613.09
Inventory	1,961	1,340	1,528	1,625	1,700
Prepaid Expenses	-	49.29	55.84	37.1	21.22
Other Current Assets	253.51	236.85	211.05	168.31	1,384
Total Current Assets	3,495	2,652	2,979	3,123	4,356
Property, Plant & Equipment	6,275	5,471	4,995	4,265	2,108
Long-Term Investments	40	-	-	-	-
Other Intangible Assets	68.26	58.99	39.61	4.76	3.17
Long-Term Deferred Tax Assets	95.67	126.24	122.97	164.03	87.1
Other Long-Term Assets	62.94	53.94	50.92	32.13	26.02
Total Assets	10,037	8,362	8,187	7,589	6,581
Accounts Payable	582.46	326.89	450.31	321.88	445.13
Accrued Expenses	5.55	123.39	87.97	67.46	75.75
Short-Term Debt	-	357.49	100	1,562	924.69
Current Portion of Long-Term Debt	1,154	6.39	36.32	98.18	143.58
Current Income Taxes Payable	3.17	20.16	0.76	2.13	10.23
Current Unearned Revenue	-	70.22	21.72	33.12	18.38
Other Current Liabilities	386.54	55.73	99.55	302.05	94.2
Total Current Liabilities	2,131	960.27	796.63	2,387	1,712
Long-Term Debt	50.1	-	6.39	42.3	131.11
Long-Term Unearned Revenue	-	-	-	-	0.08
Pension & Post-Retirement Benefits	25.89	-	-	-	-
Other Long-Term Liabilities	12.01	13.98	13.34	11.45	6.51
Total Liabilities	2,219	974.25	816.36	2,441	1,850
Common Stock	233.92	233.92	233.92	221.65	221.65
Additional Paid-In Capital	-	4,044	4,044	2,090	2,090
Retained Earnings	-	3,085	3,077	2,825	2,415
Comprehensive Income & Other	7,584	25.08	15.84	10.75	4.27
Shareholders' Equity	7,818	7,388	7,371	5,148	4,731
Total Liabilities & Equity	10,037	8,362	8,187	7,589	6,581
Total Debt	1,204	363.88	142.71	1,703	1,199
Net Cash (Debt)	-1,116	-246.87	313.97	-1,290	-561.19
Net Cash Per Share	-47.71	-10.55	13.72	-58.22	-26.10
Filing Date Shares Outstanding	23.4	23.39	23.39	22.17	22.17
Total Common Shares Outstanding	23.4	23.39	23.39	22.17	22.17
Working Capital	1,364	1,692	2,182	735.59	2,644
Book Value Per Share	334.03	315.84	315.10	232.25	213.44
Tangible Book Value	7,749	7,329	7,331	5,143	4,728
Tangible Book Value Per Share	331.12	313.32	313.41	232.04	213.30
Buildings	-	1,698	1,544	504.8	376.53
Machinery	-	4,107	3,005	1,478	1,153
Construction In Progress	-	215.35	729.27	2,307	514.91